(Q33904631)

29 July 2017

1 reference

title

Achieving tissue-level perfusion in the setting of acute myocardial infarction (English)

1 reference

29 July 2017

D Mukherjee

1

1 reference

29 July 2017

D J Moliterno

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

85

1 reference

29 July 2017

issue

8A

1 reference

29 July 2017

page(s)

39C-46C

1 reference

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

TIMI flow and surrogate end points: what you see is not always what you get

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Reperfusion revisited: beyond TIMI 3 flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Selective platelet deposition during focal cerebral ischemia in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

"Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Evidence for decreased coronary flow reserve in viable postischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Distal coronary flow velocity immediately after direct angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Recovery of coronary flow and left ventricular function after abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thromb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Recovery of Myocardial Perfusion in Acute Myocardial Infarction After Successful Balloon Angioplasty and Stent Placement in the Infarct-Related Coronary Artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Early changes in myocardial perfusion patterns after myocardial infarction: relation with contractile reserve and functional recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Rapid reversal of no-reflow using Abciximab after coronary device intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Incidence and treatment of 'no-reflow' after percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Features and outcome of no-reflow after percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900818-3

10.1016/S0002-9149(00)00818-3

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference